Disc Medicine, Inc. (IRON) Form 8-K — Jun 30, 2026

$IRONForm 8-KItems 1.01, 2.03Filed Jun 30, 2026, 4:16 PM ET0001193125-26-290542Original filing

Disc Medicine entered into a First Amendment to its Loan and Security Agreement with Hercules Capital on June 25, 2026, drawing down $30 million from its Tranche 1-B Advance and restructuring the remaining $50 million Tranche 1-C into two $25 million tranches with extended availability periods through March and April 2027. The amendment also extended the drawdown deadlines for Tranche 2 and Tranche 3 Advances to December 15, 2027 and June 30, 2028, respectively, providing the company with a longer runway to access additional debt capital.

Key figures

Debt Amount: 30000000
Tranche 1 D: $25,000,000 available through April 30, 2027
Tranche 1 C split a: $25,000,000 available through March 31, 2027
Tranche 1 B drawdown: $30,000,000
Tranche 1 C original: $50,000,000
Tranche 2 drawdown deadline: December 15, 2027
Tranche 3 drawdown deadline: June 30, 2028
Minimum cash covenant testing date: July 1, 2028

Price after filing

1 day: +2.5%7 days: +9.1%30 days: +0.7%

Close on the filing date to close N calendar days later (from $73.14). Historical, not a forecast.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.